Skip to content
‹ Back to IndustriesSciences

Can Scientists Use ChatGPT for Scientific Research?

In December 2022, University of Colorado School of Medicine’s Casey Greene and Perelman School of Medicine’s Milton Pividori performed an experiment using ChatGPT to improve three research papers. The focus of the experiment was to see whether OpenAI’s language models were robust enough to supplement academic papers to make writing and revising manuscripts more efficient….

This story was produced through MarketScale. See how Sciences teams put it to work with Executive Thought Leadership.

By carey.scott · · Ai ToolsArtificial IntelligenceChatgptResearch Methods
Share

Key takeaways

01

In December 2022, University of Colorado School of Medicine’s Casey Greene and Perelman School of Medicine’s Milton Pividori performed an experiment using ChatGPT to improve three research papers.

02

The focus of the experiment was to see whether OpenAI’s language models were robust enough to supplement academic papers to make writing and revising manuscripts more efficient….

Free workspace

Turn your Sciences expertise into content.

Record interviews, organize footage, and write with AI on a free trial of the MarketScale platform for qualifying companies. No demo required, no credit card.

Try it Free

In December 2022, University of Colorado School of Medicine’s Casey Greene and Perelman School of Medicine’s Milton Pividori performed an experiment using ChatGPT to improve three research papers. The focus of the experiment was to see whether OpenAI’s language models were robust enough to supplement academic papers to make writing and revising manuscripts more efficient. Surprisingly for the academic community, the experiment proved successful, with their research finding that OpenAI’s models “can capture the concepts in the scholarly text and produce high-quality revisions that improve clarity.” More readable and accessible academic manuscripts sounds like a win for everyone involved, but how else can AI-supported chatbots support the academic community? Greene and Pividori’s research leaves many wondering whether scientists dealing in rigorous and highly-technical subjects can leverage ChatGPT for scientific research from start to finish.

ChatGPT was launched in November 2022 and got over 1 million users within the first week of its launch; OpenAI’s tool is clearly highly popular and gaining mainstream appeal, validating new use cases every week. The tool can perform complex tasks that save loads of time and energy, and can produce text like poetry, prose, computer code, and even topical research ideas. However, it’s not a perfect tool by any stretch. High level thought leaders in the tech community, including Steve Wozniak, warn that ChatGPT’s text generation can be riddled with errors. Obviously, anything of academic quality can’t have erroneous revisions applied.

Scientists use various types of research methods to gather information to develop their hypotheses and supplement academic texts, including digging for sources, conducting hypothetical scientific models to prove their research, running surveys for new data, and more. With ChatGPT Plus hot on our heels, should scientists start to use ChatGPT for scientific research? How confident can they be in its efficacy? Justin Bean, author of What Could Go Right and an experienced sustainability and smart city strategist working with Fortune 500s and cutting-edge start-ups, weighs in with his take. Bean is highly familiar with the research process; he spent many years as a clean tech and green energy consultant, where he conducted layered and rigorous research of financial data, venture capital investments, trend reports and more.

Justin’s Thoughts:

“So, if Siri gave everyone a digital assistant, ChatGPT gives everyone a digital intern. This means it can do way more work for us and including in science. So, a lot of the work in science and data analysis is all about gathering and blending and cleaning and compiling data, and about making interpretations that lead to some kind of insight, which they can then take and do science with.

Now because of ChatGPT, a lot of that early stage can be done by an AI and that’ll free up scientists to have a lot more time doing the science. But not just that, it’s going to free a lot of people up to be able to do science who aren’t conventional scientists and people who don’t have PhDs. This is because it’s going to do a lot of that initial work and be able to explain it in everyday layman’s terms for you and me to be able to do the science.

And I think that’s going to democratize a lot of inventions and a lot of science as innovators from around the world and different perspectives, it will bring their perspectives to science and leverage the information they can get through chatGPT. Now, as this develops, all these AIs are going to become more and more specialized.

So you may have a specialized artificial intelligence for cancer science and detection, and another one for weather science or climate science. Many different ones will proliferate. In addition, we’re going to have autonomous economic agents that will take that information and go out and acquire materials or goods or contracts for us just to make a lot of that process a lot easier and make us all more effective.”

Your experts belong here

Every story in MarketScale Sciences starts with a company putting its lab directors, applications scientists, and field specialists on the record. Buyers are already reading this topic. The only question is whose experts they find.

Lab and research buyers verify before they trial, and your scientists give them something credible to verify against.

Book DemoSee how it works15 minutes, straight to a calendar.

About the author

C
carey.scott
B2B Weekly

The week in Sciences, and sixteen other industries, every Monday.

Ten stories, one-line takes, five minutes. Free.

Sciences: are you visible to AI?

Before they reach out, Sciences buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free Trial

You just read one Sciences expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your lab directors, applications scientists, and field specialists into the articles, video, and social content Sciences buyers are searching for. Start a free trial and see it with your own people. For qualifying companies, no credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What your free trial includes

Hands-on access to the MarketScale platform
Media requests to your crowd, remote recording, AI writing tools
No demo required. No credit card.
For qualifying companies. Company confirmation required.

More Sciences Insights

Peptide drug runs can stall on late raw materials, Frost & Sullivan and Medtide find

Peptide drug runs can stall on late raw materials, Frost & Sullivan and Medtide find

Frost & Sullivan and Medtide's 2026 white paper on peptide and oligonucleotide drugs ties contract manufacturer selection to program stage. Its sharpest point is that a late resin, amino acid or nucleotide building block can stall a campaign even with plant capacity free. Supplier depth belongs in CDMO qualification.

  • 01Open capacity at a contract manufacturer means little if a nonstandard amino acid or a modified nucleotide building block arrives late, so the supplier list deserves the same scrutiny as the capacity reservation.
  • 02What makes a good CDMO changes as a program matures: speed of problem solving decides early clinical timelines, while proven scale-up, raw-material access, reserved capacity and site-to-site transfer decide launch readiness.
  • 03A useful question for any prospective partner is which critical inputs for a given molecule already have a second qualified supplier, because switching sources later can trigger extra quality testing.

Nov 22, 2026

Merck's $550 million lab was built for robots whose specs weren't final

Merck's $550 million lab was built for robots whose specs weren't final

Merck's $550 million ADVANCE lab in West Point, Pennsylvania, which opened in October 2026, reserved floor space for robots before some of them had final dimensions. Containment sits inside robotic work cells, space and utilities were sized for the largest expected machines, and validation waited until construction ended. Other lab capital projects can reuse that order of work.

  • 01When robotic platforms carry their own enclosures, walls are needed mainly where the science or access control demands them, and the open floor plan is designed to make future equipment swaps easier without automatically forcing new room build-outs.
  • 02Merck planned for the largest expected robot sizes and highest utility needs, using lessons from its 2023 Spring House lab, according to Lab Design News. Teams without a previous project to learn from could find those limits harder to set.

Nov 21, 2026

Keller’s case for carbs as key fuel for post-workout muscle repair

Keller’s case for carbs as key fuel for post-workout muscle repair

In a NuLiv Science segment, nutrition scientist and dietitian Dr. Rosa Keller argues that carbohydrate (glucose) is a key fuel for mitochondrial ATP after resistance training and that clients often under-eat carbs. The article cites reviews emphasizing carbohydrate for glycogen restoration (including John Ivy’s 1.2 g/kg/hour post-exercise target), describes protein as a co-ingested partner in recovery, and notes ketogenic-diet findings that may benefit aging mitochondria.

  • 01John Ivy's post-exercise carbohydrate target is about 1.2 grams per kilogram of body weight per hour, taken early and often, to maximize glycogen resynthesis.
  • 02Nature Metabolism describes carbohydrate as the primary fuel for ATP in most Olympic events, and Keller argues that post-exercise repair depends on mitochondria having fuel to generate ATP.
  • 03Ketogenic diets improve muscle mitochondrial mass and function with age or disease but not in athletes, Pathak and Baar concluded, so the carbohydrate rule depends on who is training.

Nov 20, 2026

Explore More Sciences Insights

Read more expert perspectives from across Sciences.

Browse Sciences Hub

About the Expert

C
carey.scott

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Sciences and beyond.

Book a Demo

Or call us. No forms required. We pick up. 214-945-2512